We are live on ! Find out more
EAM

Eventide Asset Management Portfolio holdings

AUM $6.05B
1-Year Est. Return 76.64%
This Fund
S&P 500
This Quarter Est. Return
+4.55%
1 Year Est. Return
+76.64%
3 Year Est. Return
+247.17%
5 Year Est. Return
+285.6%
10 Year Est. Return
+2,546.71%
AUM
$3.29B
AUM Growth
+$383M
Cap. Flow
+$337M
Cap. Flow %
10.23%
Top 10 Hldgs %
35.01%
Holding
141
New
13
Increased
43
Reduced
18
Closed
25

Top Buys

Rank Stock Value
1
ZGNX
Zogenix, Inc.
ZGNX
+$38.1M
2
TMX
Terminix Global Holdings, Inc.
TMX
+$35.9M
3
EXAS
Exact Sciences
EXAS
+$35.8M
4
SRPT icon
Sarepta Therapeutics
SRPT
+$33.8M
5
MYOV
Myovant Sciences Ltd.
MYOV
+$27.1M

Top Sells

Rank Stock Value
1
BLUE
bluebird bio
BLUE
+$34.5M
2
ALTR
Altair Engineering Inc
ALTR
+$23.1M
3
ICPT
Intercept Pharmaceuticals, Inc.
ICPT
+$22.9M
4
OPLN
Openlane
OPLN
+$21.6M
5
QURE icon
uniQure
QURE
+$17.8M

Sector Composition

Rank Sector Weight
1 Healthcare 47.89%
2 Technology 19.59%
3 Industrials 8.32%
4 Consumer Discretionary 7.68%
5 Communication Services 3.93%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow
VRTX icon
126
Vertex Pharmaceuticals
VRTX
$121B
– –
-26,000
Closed -$4.78M
VTR icon
127
Ventas
VTR
$48B
– –
-6,000
Closed -$383K
WDC icon
128
Western Digital
WDC
$188B
– –
-3,969
Closed -$144K
WVE icon
129
Wave Life Sciences
WVE
$1.09B
– –
-170,400
Closed -$6.62M
ALTR
130
DELISTED
Altair Engineering Inc
ALTR
– –
-628,000
Closed -$23.1M
VIRX
131
DELISTED
Viracta Therapeutics, Inc. Common Stock
VIRX
– –
-170,442
Closed -$7.25M
VBIV
132
DELISTED
VBI Vaccines, Inc. New Common Stock (Canada)
VBIV
– –
-61,667
Closed -$3.46M
ICPT
133
DELISTED
Intercept Pharmaceuticals, Inc.
ICPT
– –
-205,000
Closed -$22.9M
CVA
134
DELISTED
Covanta Holding Corporation
CVA
– –
-42,000
Closed -$727K
XLRN
135
DELISTED
Acceleron Pharma
XLRN
– –
-128,900
Closed -$6M
CCI.PRA
136
DELISTED
Crown Castle International Corp. 6.875% Mandatory Convertible Preferred Stock, Series A
CCI.PRA
– –
-1,355
Closed -$1.6M
WBC
137
DELISTED
WABCO HOLDINGS INC.
WBC
– –
-134,000
Closed -$17.7M
ARQL
138
DELISTED
Arqule Inc
ARQL
– –
-2,100,000
Closed -$10.1M
2 3 4 5
6

Similar funds

HPG
Harvest Portfolios Group Oakville, Ontario, Canada $6.06B AUM 16.63% 1-Year Est. Return
EMPI
Elo Mutual Pension Insurance Espoo, Finland $6.06B AUM 24.33% 1-Year Est. Return
RCG
Ruane, Cunniff & Goldfarb New York $6.03B AUM 12.06% 1-Year Est. Return
JWBC
John W. Bristol & Co New York $6.08B AUM 16.51% 1-Year Est. Return
AAM
Advisors Asset Management Monument, Colorado $6.01B AUM 24.74% 1-Year Est. Return
AA
AQR Arbitrage Greenwich, Connecticut $6.09B AUM 27.01% 1-Year Est. Return
CM
CastleKnight Management New York $6B AUM 121.87% 1-Year Est. Return
CIS
Capital International Sarl Los Angeles, California $6.11B AUM 32.29% 1-Year Est. Return

Eventide Asset Management's Q2 2019 Portfolio in Review

As of Q2 2019, Eventide Asset Management held 141 positions worth $3.29B, up 13% from $2.91B the previous quarter. Its ten largest holdings account for 35% of the portfolio.

Eventide Asset Management deployed $337M of net new capital in Q2 2019, opening 13 new positions and adding to 43 existing holdings. Its largest new stake was Terminix Global Holdings, Inc.: 698,000 shares worth $36.4M.

By sector, the portfolio is most concentrated in Healthcare at 48% of assets, up from 47% a quarter earlier, followed by Technology and Industrials.

On the sell side, the largest reduction was bluebird bio, an estimated $34.5M trimmed.

  • Eventide Asset Management's largest Q2 2019 buy was Terminix Global Holdings, Inc.: 698,000 shares worth $36.4M.
  • Eventide Asset Management added most to Zogenix, Inc. in Q2 2019, an estimated $38.1M increase.
  • Eventide Asset Management's biggest Q2 2019 reduction was bluebird bio, cutting an estimated $34.5M.
  • Eventide Asset Management fully exited Altair Engineering Inc in Q2 2019, selling an estimated $23.1M.
  • Eventide Asset Management's ten largest holdings make up 35% of its $3.29B portfolio in Q2 2019.
  • Eventide Asset Management opened 13 new positions and closed 25 in Q2 2019.
  • Eventide Asset Management's portfolio value rose 13% quarter-over-quarter to $3.29B.

Based on Eventide Asset Management's 13F filing for Q2 2019, filed 14 Aug 2019.